Clinical Efficacy of Chelation Therapy in Patients With Low-Risk Myelodysplastic Syndrome

Klinicheskaya Onkogematologiya/Clinical Oncohematology- Russian Federation

doi 10.21320/2500-2139-2019-12-2-120-124

Full Text

Abstract

Available in

Categories

Date

March 1, 2019

Authors

Publisher

Practical Medicine Publishing House

Related search

Clinical Efficacy of Pharmacological Therapy in Patients With Burning Mouth Syndrome

Actual problems in dentistry

English

Red Blood Cell Transfusion Independence Following the Initiation of Iron Chelation Therapy in Myelodysplastic Syndrome.

English

Prognostic Markers of Efficiency of Immunosupressive Therapy in Patients With Myelodysplastic Syndrome

English

Androgen Therapy for Patients With Lower-Risk Myelodysplastic Syndrome and Significant Cytopenia: A Retrospective Study

British Journal of Haematology

English

Iron Chelation Therapy in Myelodysplastic Syndromes: Where Do We Stand?

Expert Review of Hematology

English

Safety and Efficacy of Azacitidine in the Treatment of Elderly Patients With Myelodysplastic Syndrome

Clinical Interventions in Aging

English

Impaired Expression of Focal Adhesion Kinase in Mesenchymal Stromal Cells From Low-Risk Myelodysplastic Syndrome Patients

Frontiers in Oncology

Cancer Research

English

Survival Advantage With Decitabine Versus Intensive Chemotherapy in Patients With Higher Risk Myelodysplastic Syndrome

Cancer Research

English

Could Haemochromatosis ( HFE ) Gene Mutations Affect Response to Iron Chelation in Myelodysplastic Syndrome?

British Journal of Haematology

English